Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

Share Price Information for FD Technologies (FDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,320.00
Bid: 1,318.00
Ask: 1,322.00
Change: 4.00 (0.30%)
Spread: 4.00 (0.303%)
Open: 1,336.00
High: 1,338.00
Low: 1,314.00
Prev. Close: 1,316.00
FDP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Formation of FD Labs

10 Sep 2015 07:00

RNS Number : 5937Y
First Derivatives PLC
10 September 2015
 



10 September 2015

 

First Derivatives plc

("FD" or the "Company")

 

Formation of FD Labs

 

FD (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services, announces the formation of FD Labs, its new R&D division based in Ottawa, Canada.

 

Collaborating with FD's global product teams, the mission of FD Labs will be to identify, innovate and develop new software product opportunities in key emerging areas such as SaaS analytics, Fast Data visualisation and the Internet of Things. It will also focus FD's global expertise in embedded software, programming languages, Cloud/SaaS environments, User Experience and IDE technology, machine learning and predictive analytics.

 

FD is also pleased to announce that industry luminary Dave Thomas and his long-time collaborator Dr. Brian Barry are both joining FD and will play key roles in advancing its innovation agenda. Dave will become FD's Chief Scientist with responsibility for new product strategy, technology outreach and evangelism. Brian will become Head, FD Labs with responsibility to manage and grow the Labs.

 

Dave Thomas commented: "The power and elegance of kdb+ has been understood for many years in the world of high performance finance. FD now has a unique opportunity to lead the way and expand the reach of kdb+ into exciting new markets such as the Internet of Things, Cyber Security, Visual Analytics and Pharma."

 

Brian Conlon, Chief Executive Officer of FD, commented: "Industry dynamics are moving in our favour as enterprises embrace streaming analytics, which plays to the strengths of kdb+. We are excited to have two of the IT industry's most respected pioneers on our team helping us advance the development of the world's leading structured database with a feature-rich enterprise platform that makes the technology straightforward to develop and manage."

 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Finance Director

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc

(Nominated Adviser and Broker)

Dominic Emery

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 4000

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

 

 

Walbrook PR

Paul Cornelius / Nick Rome / Helen Cresswell / Sam Allen

 

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with nearly 20 years of experience of working with some of the world's largest finance, technology and energy institutions. FD is the developer of the world-leading database technology kdb+. FD employs over 1,400 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

 

Dave Thomas, Chief Scientist, FD

Dave is co-founder and past Chairman of Bedarra Research Labs (BRL), creators of the Ivy visual analytics workbench. Prior to this he was founder and past CEO of Object Technology International (OTI), becoming CEO of IBM OTI Labs after its sale to IBM. With a distinct ability to translate research into competitive products, he is known for his contributions to Object Technology including IBM VisualAge and Eclipse IDEs, Smalltalk and Java virtual machines. Dave is a renowned keynote speaker with an impressive breadth of business experience and technical depth. He is a thought leader in large-scale software engineering and a founding director of the Agile Alliance. An Association of Computing Machinery Distinguished Engineer with close links to the R&D community, Dave is an adjunct research professor at Carleton University in Canada and has held past positions at UQ and QUT in Australia. He has been a business and technical advisor to many technology companies including Kx Systems. Dave is founder and Chairman of the YOW! Australia and Lambda Jam conferences, and is a GOTO Conference Fellow.

 

Dr. Brian Barry, Head, FD Labs

Brian is co-founder and past CEO of Bedarra Research Labs. Prior to this he held several executive positions at Object Technology International (OTI) including Chief Scientist and CTO. He became President of IBM OTI Labs after OTI's acquisition by IBM and later succeeded Dave Thomas as CEO. Under their leadership, OTI developed the Eclipse Platform, J9 Java VM, IBM VisualAge for Java, and IBM VisualAge MicroEdition for embedded systems. Brian's published research reflects a broad spectrum of interests spanning simulation, Object-Oriented applications, systems integration, embedded systems and software engineering. He co-authored the ANSI Smalltalk standard, and has been an active participant in research granting boards and conference committees. Brian has a long history of involvement with open source software, and is a founder of both the Eclipse Foundation (www.eclipse.org) and Open Health Tools (www.openhealthtools.org), where he served as CTO from its inception until 2014. He holds a Ph.D. in mathematics from Queen's University.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGGLKLNGKZM
Date   Source Headline
7th Jun 201810:43 amRNSHolding(s) in Company
5th Jun 20184:51 pmRNSNotice of AGM
1st Jun 20184:14 pmRNSIssue of Equity
22nd May 20187:00 amRNSPreliminary results for the year ended 28 Feb 2018
17th May 20187:02 amRNSKx provides rapid access to unstructured data
25th Apr 20187:00 amRNSTrading update and Notice of Results
3rd Apr 201810:00 amRNSTotal Voting Rights
23rd Mar 20187:00 amRNSEnterprise Securities Market Notice
19th Mar 201810:09 amRNSIssue of Equity
28th Feb 20189:01 amRNSTotal Voting Rights
20th Feb 20187:00 amRNSContract Win in Gaming
7th Feb 20187:00 amRNSEnterprise Securities Market Notice
1st Feb 20185:23 pmRNSIssue of Equity
31st Jan 20183:40 pmRNSTotal Voting Rights
15th Jan 20187:00 amRNSAppointment of Non-Executive Director
4th Jan 20187:00 amRNSEnterprise Securities Market Notice
29th Dec 20177:00 amRNSTotal Voting Rights
27th Dec 20177:00 amRNSIssue of Equity
19th Dec 20174:06 pmRNSDirector/PDMR Shareholding
18th Dec 20174:07 pmRNSIssue of Equity
14th Dec 20177:00 amRNSEnterprise Securities Market Notice
11th Dec 20177:00 amRNSTelco Acquisition
7th Dec 20177:00 amRNSEnterprise Securities Market Notice
1st Dec 20174:31 pmRNSIssue of Equity
30th Nov 20178:36 amRNSTotal Voting Rights
22nd Nov 201710:35 amRNSHolding(s) in Company
21st Nov 20174:54 pmRNSHolding(s) in Company
16th Nov 20177:00 amRNSEnterprise Securities Market Notice
10th Nov 201712:32 pmRNSIssue of Equity and Dividend Timetable Amendment
7th Nov 20177:00 amRNSHalf Yearly Report
6th Nov 20177:00 amRNSKx selected by Red Bull Racing
13th Oct 20177:00 amRNSNotice of Results
2nd Oct 20179:09 amRNSTotal Voting Rights
19th Sep 20177:00 amRNSMajor Machine Learning Investment in Kx Technology
5th Sep 20177:00 amRNSEnterprise Securities Market Notice
30th Aug 20173:04 pmRNSIssue of Equity
23rd Aug 201712:20 pmRNSHolding(s) in Company
31st Jul 201711:58 amRNSTotal Voting Rights
28th Jul 20177:00 amRNSEnterprise Securities Market Notice
25th Jul 20177:00 amRNSHolding(s) in Company
24th Jul 20174:26 pmRNSIssue of Equity from exercise of Share Options
7th Jul 20177:00 amRNSEnterprise Securities Market Notice
3rd Jul 20174:23 pmRNSIssue of Equity from exercise of Share Options
30th Jun 201710:48 amRNSTotal Voting Rights
23rd Jun 20171:50 pmRNSAGM Statement
6th Jun 20177:00 amRNSEnterprise Securities Market Notice
2nd Jun 20179:56 amRNSAnnual Report 2016/17 and AGM Notice
30th May 20175:13 pmRNSDirector/PDMR Shareholding
30th May 20175:12 pmRNSDirector/PDMR Shareholding
30th May 20172:06 pmRNSIssue of Equity from exercise of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.